Pharma major Cipla is scheduled to report its Q2FY21 earnings tomorrow (06 November).
CNBC-TV18 expects a revenue growth of 5 percent at Rs 4,645 crore, while earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to go up by 12 percent at Rs 1,016 crore.
Margins is likely to go up by almost 90 basis points and profit is expected to go up by 19 percent.
Watch video to know more.